Skip to content
  • There are no suggestions because the search field is empty.
Toggle Open Icon-1
menu-close
Cheryl_Bio Headshot-1

PARTNER

Cheryl Allen

BS Pharm, MBA

 

Cheryl works with pharmaceutical manufacturers and other stakeholders in the channel leveraging her two plus decades of Industry experience to design business strategies to effectively deliver value in patient access and support services. Cheryl has a unique ability to truly empathize with all constituents to create the optimal patient and prescriber journey. She understands the benefits and hurdles and is skilled at using process, data, and technology to create patient centric solutions.

Cheryl brings more than 25 years of industry experience, with work in independent and specialty pharmacy, as well as in managed care consulting and health care IT. Prior to Curatio, Cheryl served as Chief Growth Officer at PANTHERx, Executive Vice President, Business Development at Specialty Pharmacy Nursing Network and EVP of Business Development and Industry Relations at Asembia. Before Asembia, Cheryl was Principal Consultant at Blue Fin Group and Cheryl served as Vice President of Business Development and Industry Relations at Diplomat. Prior to Diplomat, Cheryl was Senior Director of Clinical Services at Sanovia Corporation, where she managed new product development and sales support. Cheryl also held roles with Priority HealthCare as a pharmacist-in-charge for oncology and lead pharmacist for pain management. Cheryl founded C. Allen & Associates, a firm focused on managed care consulting, and Eden Drug Company, an independent specialty pharmacy. Cheryl earned her Bachelor of Science in pharmacy at Samford University’s McWhorter School of Pharmacy, in Birmingham, Alabama and her MBA at Saint Joseph’s University Erivan K. Haub School of Business with a focus in pharmaceutical and health care marketing in Philadelphia, Pennsylvania.

Blogs

 

ARTICLE: Enhancing Patient Access and Support Through Technology
By Curatio Advisors 21 September 2024

August 9, 2024, in Pharmaceutical Commerce publication, Cheryl Allen, BS Pharm, MBA, and Jon...

read more
BLOG: FDA Approval Implications for Patient Access to Therapy
By Curatio Advisors 21 September 2024

The pace of innovation in the pharmaceutical pipeline is incredible with novel...

read more
CASE STUDY: Commercial Services Assessment; Business Case Design, Scope, & Rationalization
By Curatio Advisors 14 September 2024

Commercial Services Assessment; Business Case Design, Scope, & Rationalization Support of a...

read more

CONNECT WITH US

Grow Your Bussiess with us

Sed amet dolor penatibus sed at posuere justo, lacinia neque.Lorem ipsum dolor sit amet, consectetur adipiscing elit. Leo nec felis at pellentesque. Sed amet dolor penatibus sed at posuere justo, lacinia neque.Lorem ipsum dolor sit amet, consectetur adipiscing elit.